![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Chi I. (1994) Use of multiple clips for tubal occlusion in interval laparoscopic sterilization: circumstances and consequences. Contra-ception, 50, 409–416.
- El-Mowafi D.M. and Diamond M.P. (2003) Fallopian tube. Available at: http://www.gfmer.ch/International_activities_En/El_Mowafi/Fal-lopian_tube.htm.
- Penny G.C., Souter V., Glasier A. et al. (1997) Laparoscopic sterilisation: opinion and practice among gynaecologists in Scotland. British Journal of Obstetrics and Gynaecology, 104, 71 —77.
- Royal College of Obstetricians and Gynaecologists (RCOG) (2004) National Evidence-based Guidelines. Male and Female Sterilisation, Recommendation 14. London, RCOG.
- Di Bisceglie C., Brocato L., Tagliabue M. et al. (2003) Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenism. Journal of Endocrinology and Investigation, 26, 206–210.
- Dowsett M., Cantwell B., Lal A., et al. (1988) Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hor-mone-releasing hormone agonist goserelin. Journal of Clinical Endocrinology and Metabolism, 66, 672–677.
- Harris Al., Carmichael J., Cantwell B.M. and Dowsett M. (1989) Zoladex: endocrine and therapeutic effect in postmenopausal breast cancer. British Journal of Cancer, 59, 97–99.
- Perry C.M. and Brogden RN. (1996) Goserelin. A review of its pharmacodynamic and pharmacolcinetic properties, and therapeutic use in benign gynaecological disorders. Drug, 51, 319–346.